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Abstract.  To study the role of (pro)collagen synthesis 
in the differentiation of rat L6 skeletal myoblasts, a 
specific inhibitor of collagen synthesis, ethyl-3,4- 
dihydroxybenzoate (DHB), was utilized.  It is shown 
that DHB reversibly inhibits both morphological and 
biochemical differentiation of myoblasts, if it is added 
to the culture medium before the cell alignment stage. 
The inhibition is alleviated partially by ascorbate, 
which along with ot-ketoglutarate serves as cofactor 
for the enzyme, prolyl hydroxylase. DHB drastically 
decreases the secretion of procollagen despite an in- 
crease in the levels of the mRNA for pmod(I) and 
proot2(I) chains.  Probably, the procollagen chains pro- 
duced in the presence of DHB, being underhydroxyl- 
ated,  are unable to fold into triple helices and are 
consequently degraded in situ.  Along with the inhibi- 
tion of procollagen synthesis,  DHB also decreases 
markedly the production of a collagen-binding glyco- 
protein (gp46) present in the ER.  The results suggest 
that procollagen production and/or processing is 
needed as an early event in the differentiation pathway 
of myoblasts. 
T 
HE terminal  differentiation  of myoblasts begins with 
their withdrawal from the cell cycle and synthesis of a 
new set of proteins.  The mononucleated cells then un- 
dergo a series of events including  cell fusion and synthesis 
and assembly of myofibrillar proteins to form muscle (for re- 
view see Sanwal,  1979;  Pearson,  1981; Wakelam,  1985). 
Controlling  the onset and progression of this process is a 
complex set of interactions  between myoblasts and their en- 
vironment. Some of the regulatory proteins induced within 
the cell have recently been identified (Wright et al.,  1989), 
but little is known of the environmental  clues or signals at 
the membrane that allow differentiation  to proceed. 
Several types of evidence point to the importance of ex- 
tracellular  matrix molecules as part of the signaling mecha- 
nism in myogenesis.  (a) Collagen  coating  of tissue culture 
dishes enhances the differentiation  of primary avian  myo- 
blasts (Hauschka and Konigsberg,  1966; de la Haba et al., 
1975). (b) The addition  of RGDS (arg-gly-asp-ser)  peptide 
to myoblast cultures  (which interferes  with binding  to sev- 
eral matrix molecules) or an antibody to cell surface matrix 
receptors (anti-CSAT) inhibits  myoblast fusion and further 
differentiation  (Ruoslahti  and  Pierschbacher,  1987; Buck 
and Horwitz, 1987; Menko and Boettiger, 1987). (c) The ad- 
dition of exogenous fibronectin decreases fusion (Podleski et 
al.,  1979).  Thus,  matrix  components supplied  externally 
influence the course of myoblast fusion. 
There is also indirect  evidence that myoblasts play an ac- 
tive role in shaping their matrix and this may be important 
for differentiation.  Myoblasts do synthesize several different 
matrix  molecules including  collagen types I  and III,  and 
fibronectin  (Chiquet  et al.,  1981; Mayne and  Sanderson, 
1985; Nusgens et al., 1986). The form of the fibronectin ma- 
trix is altered concomitant with fusion,  and integrin  recep- 
tors are also redistributed  (Damsky et al., 1985). Treatment 
of cultures with transforming growth factor/~ results in inhi- 
bition of fusion which may be related  to the action of the 
growth factor in causing increased  deposition of extracellu- 
lar matrix (Florini et al., 1986; Massague et al., 1986; Olson 
et al., 1986). Furthermore, analogues of proline that inhibit 
collagen formation also inhibit fusion (de la Haba and Bricker, 
1981). Taken together,  these observations point to an active 
role for the myoblasts in forming the matrix. 
Our recent studies  of a collagen-binding  protein (gp46) 
have also suggested a requirement  for collagen synthesis in 
myogenesis:  mutants  with decreased levels of the protein 
(and  abnormal  collagen  synthesis)  lack the ability to fuse 
(Cates et al.,  1984,  1987).  The recent discovery of com- 
pounds  that  specifically  inhibit  collagen  hydroxylation 
(reviewed in Kivirikko  et al.,  1989) offered a different ap- 
proach to this question of the need for endogenous collagen. 
In this report, we have examined the effects of one such in- 
hibitor on myogenesis in culture; the results support the idea 
of a critical  role for the newly made matrix molecules early 
in myogenesis. 
Materials and Methods 
Cells and Cell Culture 
A highly myogenic subclone of the L6 rat skeletal myoblast cell line origi- 
nally isolated by Yaffe (1968) was cultured in MEM obtained from Gibco 
Laboratories (Grand Island,  NY).  The medium was supplemented with 
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fusion was quantitated by determining the proportion of nuclei within myo- 
tubes as described by Morris and Cole (1972). 
Collagen Assays 
For the determination of collagen production, cells were plated at an initial 
density of 105 cells per 60-mm plate. After 48 h of growth the incubation 
medium was replaced by fresh medium containing DHB. After 3 h of prein- 
cubation with DHB, 50 ~tCi of L-[2,3-3Hlproline (specific activity,  29.1 
Ci/mmol) was added and labeling was continued for 13 h. At the end of this 
period, medium was collected and supplemented  with a solution of  protease 
inhibitors (0.5 mM PMSF, 2 ~g leupeptin/ml, and 1 mM EGTA). After col- 
lecting the medium, cells were washed extensively with cold PBS and lysed 
by adding 1 ml of hot Ix Laemmli sample buffer (Laemmli, 1970) directly 
on the culture plate. Lysed contents were passed three times through a 0.5- 
in, 27-gauge needle and cleared by centrifuging in a microfuge for 10 min 
at room temperature. Aliquots of the medium and cell lysates were precipi- 
tated with cold TCA (10%, final concentration). BSA was added to the cell 
lysates to facilitate TCA precipitation of proteins. After incubation for 30 
min  on  ice,  the precipitated material  was  recovered by centrifugation. 
Precipitates were washed three times with cold 10% TCA and then hydro- 
lyzed in 6 N HCI in evacuated sealed tubes for 18 h at 115°C, dried using 
a flash evaporator, and dissolved in 0.2 M sodium citrate buffer, pH 2.2. 
The hydrolyzates were analyzed on an autoprogrammed single-column ana- 
lyzer (Beckman Laboratories Inc., Palo Alto, CA). Peaks corresponding to 
proline and hydroxyproline were counted for radioactivity. 
To study the synthesis of  procollagens, myohlasts were preincubated with 
0.2 mM ethyl-3,4-dihydroxybenzoate  (DHB) j for 3 h, 25 ~tCi/ml of [3H]pro- 
line was then added to the medium and labeling was continued for 6 h. At 
the end of this period, medium was collected and supplemented with a mix- 
tare ofprotease inhibitors. Procollagens were precipitated by adding ammo- 
nium sulfate to 30% of saturation. After overnight precipitation in the cold, 
precipitates were recovered by centrifugation. These were then washed 
twice with cold 70% ethanol. Finally,  precipitates were vacuum dried and 
dissolved in 500 ~1 of 1×  Laemmli sample buffer.  Procollagens were sepa- 
rated by SDS-PAGE as described by Laemmli (1970). 
To examine incorporation of proteins into extracellular matrix, cells la- 
beled with [3H]proline  were rinsed and extracted with a  urea-containing 
buffer as described (Ignotz and Massague,  1986).  Samples were run on 
SDS-PAGE and autoradiographed. 
Immunoprecipitation 
Ceils were seeded at an initial density of 105 per 60-ram tissue culture 
plate. After 48 h of growth, the desired amount of DHB was added directly 
to the medium. After 48 h cells were labeled with 50/~Ci/ml of [3SS]methi- 
onine (1,131 Ci/mmol) in methionine-free  medium for 2 h without DHB. At 
the end of the labeling period cells were washed three times with an excess 
of ice-cold PBS. Cells were lysed directly on the tissue culture dish by add- 
ing 50 tzl of twofold concentrated RIPA buffer (20 mM sodium phosphate, 
0.3 M NaCI, 0.2% SDS, 2% sodium deoxycholate, and 2% Triton X-100) 
containing the protease inhibitors. Cells were scraped with a rubber police- 
man, passed three times through 27-gauge needle and left on ice for 20 min 
to ensure proper extraction of proteins. Insoluble material was cleared by 
centrifugation. 200 ~1 of supernatant was diluted by adding an equal volume 
of  distilled water and supplemented with BSA to 0.5 % (final concentration). 
The mixture was precleared with 25 ~tl of rabbit antimouse-coated protein 
A-Sepharose and then incubated with suitably diluted antibody for 90 min 
on ice. A further aliquot (25 pl) of coated protein A-Sepharose was added 
and incubation continued for 30 min. The protein A-Sepharose complexes 
were recovered by centrifugation, washed three times with cold 1  ×  RIPA 
buffer and the bound proteins recovered by heating the complexes with 
200 #l of Laemmli sample buffer in boiling water bath for 3 min. Released 
proteins were electrophoresed on 8.5% SDS-polyacrylamide gels. The gels 
were stained, destained, treated with EN3HANCE (DuPont Canada, Inc., 
Mississauga, Ontario), dried, and exposed to x-ray film. 
Isolation and Analysis of RNA 
Total RNA was prepared by using a modification of the procedure of Chirg- 
win et al. (1979).  Various concentrations of DHB were added to the culture 
1.  Abbreviation  used  in  this paper:  DHB,  0.2  mM ethyl-3,4-dihydroxy- 
benzoate. 
medium 48 h after plating in 100-mm plates. Either 24 (day 3) or 72 h (day 
5) after DHB treatment, the cells were scraped into guanidine thiocyanate 
buffer (5 M guanidine thiocyanate, 50 mM Tris-HCl, pH 7.5, 10 mM EDTA, 
and 10% freshly prepared 2-mercaptoethanol), and homogenized by pass- 
ing the extract through an  18-gauge  needle. DNA and denatured protein 
were separated by centrifugation through a cesium chloride cushion (5.7 M 
CsCI and 25 mM sodium acetate, pH 7.5) in a rotor (TLA 100.2;  Becktnan 
Instruments, Inc.) at  100,000  rpm for 4  h. The RNA pellets were resus- 
pended in 10 mM Tris-HCl, pH 7.5, 5 mM EDTA, and 1% N-lauroylsar- 
cosine and extracted successively with phenol/chloroform and chloroform, 
and the RNA was precipitated by ethanol. Northern blot analysis was done 
to show the specificity of the lx~lRl  and pa2R2 probes. Total RNA was 
denatured with deionized glyoxal and size separated through a 0.9% agarose 
gel buffered with 10 mM phosphate (Maniatis et al.,  1982).  After electro- 
phoresis, the RNA was transferred to BioTrans nylon membranes (Thomas, 
1980).  For quantitation, various concentrations of each RNA sample were 
slot blotted onto BioTrans nylon membranes using a Minifold II (Schleicher 
& Schuell, Inc., Keene, NH). The filters from both the Northern transfer 
and the slot blots were prehybridized at 42°C for 3 h and then hybridized 
at 42°C for 24 h in a solution containing 50% formamide, 5 x  sodium saline 
citrate (SSC) (Ix SSC =  150 mM NaCI and 15 mM sodium citrate), 5x 
Denhardt's solution (Denhardt, 1966), and denatured salmon sperm DNA. 
The hybridization solution also contained 0.1% SDS and denatured 32p-la- 
beled probes. Blots were washed twice in 2×  SSC containing 0.1% SDS 
at room temperature for 5 min each. The blots probed with the collagen 
probes were then washed twice in 0.1× SSC containing 0.1% SDS at 60°C 
for 10 rain each. The myosin light chain 2 probed blots were washed twice 
in ().Ix SSC and 0.1% SDS at 42°C for 20 rain each. Filters were exposed 
to film (XAR-5; Eastman Kodak Co., Rochester, NY) with intensifying 
screens at  -70°C  for various lengths of time.  Various  exposures were 
scanned by laser densitometry to quantitate the levels of RNA. 
DNA Probes 
Rat collagen pro-cd(1)  (palR1) and pro-cx2(I) (pa2R2) cDNA clones were 
obtained from Dr. David Rowe, University of Connecticut Medical Center, 
Farmington, CT (Genovese et ai.,  1984).  The plasmid palRl  consists of 
a  1.3-kb  insert in the Pst I/Barn HI site of pUCI8 encoding amino acids 
400-846  in the triple helical domain of the pro-otl(I) chain. The pot2R2 
plasmid contains a 900-bp insert in the Pst I site of pUCI8 encoding the 
COOH-terminal extension peptide of pro-c~2 (I). A cDNA clone for rat 
myosin light chain 2 (pMLC2-18) was obtained from Dr. B. Nadal-Ginard, 
Harvard  University, Boston, MA (Garfinkel et at.,  1982).  The plasmid 
pMLC2-18 contains a 500-bp insert in the Pst I site of pBR322 which codes 
for 102 amino acids of the COOH terminus. 
Preparation of  DNA Probes 
Recombinant plasmids were propagated in Escherichia  coil HBI01. Plasmid 
DNA was extracted using alkaline lysis (Maniatis et al., 1982) followed by 
equilibrium centrifugation in cesium chloride and ethidium bromide. The 
plasmids were digested with the appropriate restriction endonacleases. 
Each preparation was subsequently size fractionated on 0.8 % agarose gels. 
Fragments were isolated by electrophoretic transfer on to NA-45  mem- 
branes (Schleicher &  Schuell, Keene, NH). DNA probes were generated 
using a random-primed labeling kit supplied by Promega Biotec (Madison, 
WI) (Feinberg and Vogelstein, 1983). 
Results 
Effect of  DHB on Myoblast Fusion 
Addition of DHB to the medium after 48 h of growth inhibits 
myoblast fusion.  The cells continue to grow until a mono- 
layer is formed and do not show noticeable abnormalities 
(Fig.  1) aside from the lack of fusion. The dose dependence 
of fusion on DHB concentrations is shown in Fig. 2. About 
40 % inhibition of myotube formation was obtained with a 
concentration of DHB as low as 0.05 mM. Complete inhibi- 
tion of fusion occurred in the presence of 0.2 mM. It should 
be mentioned that DHB did not have any significant effect on 
the rate of growth of myoblasts. Thus, when cells were plated 
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Figure I. Effect of DHB on I-.6 myoblast morphology. After 48 h 
of growth, myoblast cultures were placed in fresh medium with or 
without DHB. After a further 3 d in culture the cells were fixed, 
stained, and photographed.  A, with 0.2 mM DHB; and B, without 
DHB. The apparent vacuoles in the myotubes are an artifact of the 
staining process. 
at a density of 1@ per 60-ram plate with and without the in- 
hibitor (0.2 mM), their number increased to  1.6  x  10  ~ in 
control plates after 4 d and to 1.4  x  106 in DHB-containing 
cultures. The effect of DHB was reversible. Under our cul- 
ture conditions, L6 myoblasts show >90%  fusion 6 d  after 
plating. When 0.2 mM DI-IB was included in the medium, 
fusion did not occur by day 7, but when DHB was withdrawn 
on day 6 by changing the medium, a burst of fusion resulted 
24 h  later. 
The effect of DI-IB  was dependent on the stage of differenti- 
ation of myoblasts. In horse serum, myoblasts rapidly divide 
and begin to align themselves after 72 h of growth. If DHB 
is added to the cultures after the alignment stage, even at a 
concentration of 0.4 mM fusion occurs normally. This sug- 
gests that only early events in myogenesis are influenced by 
DHB. The effect of DHB on myoblast fusion can be partially 
reversed by  ascorbate.  Thus,  when  1  mM  ascorbate was 
added in the medium along with 0.1 mM DHB after 48 h of 
growth, and the amount of fusion scored on day 5, the inhibi- 
tion was •70%  in the presence of DHB alone and *40% in 
the presence of both DHB and ascorbate (data not shown). 
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Figure 2. Effect of DHB on myoblast fusion. After 48 h of growth, 
culture medium was changed to medium containing the appropriate 
concentration of DHB. After a further 3 d of growth triplicate cul- 
tures  were  fixed and  stained,  and  fusion  was quantitated.  Bar 
represents  standard error. 
DHB CONCENTRATION 
Figure 3. Effect of DHB on myosin light chain 2 mRNA levels. L6 
cells  were  grown  for 48  h  before  the  incubation  medium was 
replaced by medium containing  DHB. Cells were harvested 72 h 
after the addition of DHB and total RNA isolated.  After blotting 
and hybridizing with the pMLC2-18 probe, levels were quantitated 
by laser densitometry  and normalized to untreated controls. 
Effect of  DHB on Muscle-specific  Gene Expression 
It is known that some inhibitors of myoblast differentiation 
affect both morphological as well as biochemical differentia- 
tion, while others selectively inhibit fusion, but allow induc- 
tion of genes coding for muscle-specific proteins (Pearson, 
1980; Fiszman et al.,  1980). It was thus of interest to deter- 
mine if DHB inhibits biochemical differentiation along with 
fusion. Using myosin light chain 2 as a marker of biochemi- 
cal differentiation, we observed a decrease in the formation 
of the mRNA for MLC 2  (Fig. 3) in the presence of DHB. 
This inhibition required higher levels of DHB than inhibition 
of fusion; however, 0.05 mM DHB effectively decreased fu- 
sion but did not affect MLC mRNA (compare Figs.  2  and 
3).  Thus DHB did show some selectivity. 
Inhibition of Synthesis of Collagenous  Proteins 
by DHB 
It has been shown by Sasaki et al. (1987) that DHB inhibits 
prolyl hydroxylase,  an  enzyme that  converts proline  into 
hydroxyproline,  and  thus  interferes  with  the  synthesis  of 
procollagens. In myoblasts, treatment with DHB drastically 
reduced  the  secretion  of  [3H]proline-labeled  collagenous 
proteins into the medium (Fig. 4).  This decrease was also 
reflected in a decrease in labeled proteins found in the urea- 
extractable extracellular matrix fraction (results not shown). 
Most  of  the  collagenous  proteins  found  in  the  growth 
medium were procollagen type I and procollagen type HI, as 
judged by the migration of the bands in SDS-PAGE under 
reducing conditions  and the susceptibility of the bands to 
collagenase (not shown).  To ascertain further that only the 
procollagen types of proteins were being inhibited by DHB, 
we  determined  the  levels  of [3H]hydroxyproline  in  TCA- 
precipitable proteins in the medium. As shown in Fig. 4, lev- 
els of [aH]hydroxyproline were reduced by over 60% in the 
media  of cells  treated  with  0.2  mM  DHB.  In  contrast, 
general protein synthesis was not much affected by DHB. 
Thus, when cells were labeled with [3H]tryptophan or [35S]- 
methionlne  (in  methionine-frec medium)  there  was  a  de- 
crease of only 10-14%  in radioactivity incorporated in the 
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quantitation of [3H]proline incorporation into procollagen. An au- 
toradiogram  of the separated chains is shown on the right of the 
panel:  upper  arrow  indicates the procoUagen t~l(I) chain  (which 
also contains small amounts of  the procollagen ul(IIl) chain), lower 
arrow identifies the procollagen ct2(I) chain. The relative levels of 
the procollagen chains were quantitated by laser densitometry (both 
chains combined) and are shown as a bar graph (bar l) untreated; 
(bar 2) with 0.2 mM DHB. B represents the results of hydroxypro- 
line analysis of secreted procollagen.  Bars  represent the relative 
amounts of hydroxyproline per unit cellular protein in the absence 
(bar 1) or presence (bar 2) of 0.2 mM DHB. 
presence of 0.2 mM DHB. Furthermore, when TCA-precip- 
itable proteins from the medium or labeled cells (in the pres- 
ence or absence of 0.2 mM DHB) were electrophoresed on 
Figure 5.  Effect  of aseorbic 
acid addition on secreted pro- 
collagen. After 48 h of  growth, 
cultures were treated with DHB 
(0.1  raM),  ascorbic  acid  (1 
mM), or both together. After 
24  h  of treatment,  the  cells 
were labeled for 6 h with [3H]- 
proline,  and  secreted procol- 
lagen isolated. Lane 1, no ad- 
dition;  lane 2,  DHB;  lane 3, 
ascorbic acid; and lane 4, DHB 
and  ascorbic  acid.  The  top 
arrow  indicates  procollagen 
od(IIl), the middle arrow pro- 
collagen od(I), and the lower 
arrow procollagen c~2(I). 
Figure 6. Northern blot analysis of pro-~l(I) and pro~2(I) mRNA 
in I.,6 myoblasts treated with DHB. 20 ttg of total RNA per lane 
was run on a 0.9% agarose gel after denaturation with glyoxal. Af- 
ter transfer to nylon membranes, the blots were probed with either 
ptxlRl or pot2R2 probes (,4 and B, respectively). 
SDS-polyacrylamide gels and autoradiographed,  no differ- 
ence in the distribution  of radioactivity was discernible in 
major protein bands (results not shown).  It would thus ap- 
pear that DHB is relatively specific for the inhibition of pro- 
collagen I and III, the only two procollagens known to be 
present in the myoblasts (Nusgens et al.,  1986). As with fu- 
sion, ascorbate was able to antagonize the inhibitory effect 
of DHB on the production of the procollagens.  Thus, den- 
sitometric scans of the autoradiograms in Fig. 5 show that 
the level of each procollagen band decreases to ,,,,40 % of the 
control level in the presence of 0.1  mM DHB, but only to 
~70% in the simultaneous presence of ascorbate. L6 myo- 
blasts are not able to process procollagen I  in the absence 
of ascorbate (Fig. 5), but processing is not obligatory for the 
differentiation of myoblasts. However, both production and 
processing of collagen are restored when ascorbate is added 
together with DHB in the medium. 
Levels of ProcoUagen  I mRNA in DHB-treated Cells 
The decrease in the levels of coUagenous proteins in the pres- 
ence of DHB raised the question  of whether this decrease 
could  be  due  to  a  decrease  in  the  levels  of procollagen 
mRNAs. Probes for the od(I) and ot2(I) procollagen mRNAs 
were used to examine this question.  Northern blots of total 
RNA hybridized with these probes revealed that each probe 
labeled  bands  of  the  expected  size  and  did  not  cross- 
hybridize under the conditions used (Fig. 6, Genovese et al., 
1984). When steady-state levels of od(I) and ot2(I) procolla- 
gen mRNAs in myoblasts were examined in the presence and 
absence  of various  concentrations  of DHB,  surprisingly, 
marked elevation in the levels of both procollagen mRNAs 
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Levels of/3-actin mRNA did not change significantly (not 
shown). Quantitation of these results (Table I) showed that 
mRNAs for both procollagen type I chains were elevated to 
a similar degree, hence, the ratio of the two chains does not 
change. 
Inhibition of  Biosynthesis of a Collagen-binding 
Protein by DHB 
We had earlier (Cates et al., 1984,  1987) described the char- 
acteristics of gp46,  a  collagen-binding protein from myo- 
blasts. Decreased gp46 levels in some Con A-resistant myo- 
blasts leads to the absence of differentiation in such cells 
(Cates et al.,  1984).  Gp46 is localized in the ER (Nandan 
et al.,  1988),  and appears to be involved in the assembly of 
collagen I chains. Similar proteins have been described by 
others (Kurkinen et al., 1984; Saga et al., 1987).  In view of 
the effect of DHB on collagen mRNA synthesis described 
above, it was of interest to examine whether biosynthesis of 
the  collagen-binding  protein  was  also  affected by  DHB. 
Using an immunoprecipitation procedure, we found that the 
synthesis of glM6 was inhibited by DHB in a dose-dependent 
manner (Fig. 7).  The inhibition appears to be specific be- 
cause as described earlier general protein synthesis is not 
affected by DHB. Inhibition of gp46 by DHB also occurred 
in a differentiation-defective  mutant (Cates et al.,  1984) that 
initially had only 30% of the level of gp46 compared to the 
wild-type cells (Fig. 7). 
Discussion 
A major enzyme involved in the synthesis of procollagen is 
prolyl hydroxylase that converts certain proline residues to 
hydroxyproline during the posttranslational modification of 
procollagens in the ER (Kivirikko et al.,  1989).  This modi- 
fication is essential for the subsequent folding and secretion 
of collagen.  Recently, a  class of compounds has been de- 
scribed which are analogues of both ascorbate and o~-keto- 
glutarate, and serve as effective competitive inhibitors of 
prolyl hydroxylase  (Majamaa et al., 1986). One such inhibi- 
tor  is the ethyl ester of 3,4-dihydroxybenzoate which not 
only inhibits the enzyme in vitro, but because of its hydro- 
phobic nature can penetrate cells in culture and inhibit dras- 
ticaUy the synthesis of collagen in normal and keloid human 
skin fibroblasts (Sasaki et al.,  1987) without affecting their 
viability, proliferative capacity, or plating efficiency.  Fur- 
Table L Effect of  DHB Treatment on mRNA Levels 
of  Procollagen I 
Concentration  of DHB  mRNA species 
raM  otl (I)*  ot2(l)* 
0  1.0 (1.0)*  1.0 (1.0)* 
0.1  2.2 (2.0)  2.0 (2.2) 
0.2  2.4 (3.3)  2.1  (3.6) 
* The mRNA values are given as the fold increase after treatment of L6 myo- 
blasts for 24 h with the indicated concentrations of DHB. The values were ob- 
tained  by calculating  the average  peak area/#g of total  RNA,  measured  by 
densitometric  scans  of slot  blot  data,  and  normalizing  the  data  to control 
values. 
* The values in parentheses  represent an independent experiment. 
Figure 7. Immunoprecipitation with anti-glM6 antibody. Extracts 
from L6 myoblasts and the myoblast variant (C8) were immuno- 
precipitated with monoclonal anti-gp46. Lane A,  untreated L6; 
lane B, L6 + 0.1 mM DHB; lane C, L6 + 0.3 mM DHB; lane D, 
untreated C8; and lane E, C8  +  0.3 mM DHB. 
thermore, DHB has very little effect on the synthesis of non- 
collagenous proteins in fibroblasts.  These properties made 
DHB an ideal inhibitor with which to probe the role of colla- 
gen in myoblast differentiation. 
Our results reveal DHB to be a potent but reversible inhibi- 
tor of both morphological and biochemical differentiation. 
That this inhibition was a result of the drug's effect on colla- 
gen synthesis is supported by several lines of evidence. At 
levels that inhibited differentiation completely, cell growth 
was only slightly affected and total protein  synthesis de- 
creased only by ,o10%.  Moreover, myoblasts did not fuse 
even after a much longer time in culture in the presence of 
the  drug.  Furthermore,  the  inhibition could be  partially 
reversed by treatment with ascorbate.  (A  more  complete 
reversal  might require both o~-ketoglutarate  and ascorbate, 
since DHB is competitive with both. z) Hence, the inhibi- 
tion of  differentiation  points to a role for collagen rather than 
a nonspecific effect. 
The timing of the effect of DHB on fusion suggests that an 
early event in the differentiation pathway is affected. It is 
clear that fusion per se is not affected since addition of the 
drug after the alignment phase has no effect.  New collagen 
may be needed for cell-cell recognition, adhesion, or some 
other initial step.  This finding correlates well with the pat- 
tern of collagen synthesis in L6 myoblasts, which peaks just 
as cells align and drops after fusion (Nusgens et al.,  1986). 
It is also of interest that inhibition of fusion by antibody to 
2.  We have found that tx-ketoglutarate  is toxic at doses that might reverse 
DHB effects. 
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Boettiger,  1987).  Taken together,  these results  suggest that 
the  status  of the extracellular matrix  is tested before any 
commitment to differentiate  is made.  This would also ac- 
count  for the  inhibition  of biochemical  differentiation  by 
drugs acting on the extracellular matrix. It should be noted, 
however, that the selective effect of DHB on fusion at low 
concentrations of the drug may indicate more than one site 
of action. 
The nature of the requirement for collagen is not clear.  It 
cannot be substituted  for by adding  exogenous collagen or 
procollagen,  however,  nor  by  plating  on  collagen-coated 
dishes (our unpublished observations). It may be that a par- 
ticular arrangement or location of collagen fibers, which can 
only be formed using newly synthesized procoUagen, is re- 
quired. 
Although DHB drastically decreased secretion of procol- 
lagen, levels of its mRNA actually  increased. This increase 
may  be reflected in the increased synthesis of procollagen 
chains which are unable to fold into triple helix and are con- 
sequently degraded without leaving the cell (Berg,  1986). In 
any event, the finding  points to a feedback mechanism for 
the control of procollagen mRNA such that secreted (pro) 
collagen decreases its own mRNA level. This type of mecha- 
nism has been postulated previously (Rowe and Schwartz, 
1983;  Muller et al.,  1986),  but was not evident in DHB- 
treated  fibroblasts  (Sasaki et al.,  1987). 
The reduction of gp46 (the collagen-binding protein in the 
ER (Cates et al.,  1984,  1987),  which is probably  involved 
in collagen assembly) after drug treatment,  is interesting  be- 
cause it suggests secondary effects of alterations  in collagen 
production.  Levels  of  the  variety  of  proteins  that  are 
specifically required for procollagen synthesis and secretion 
may also be regulated by feedback mechanisms. Further ex- 
periments will be necessary to determine at what level the 
regulation  of gp46 occurs as well as the generality of the 
phenomenon. 
The extracetlular  matrix is an extremely important part of 
the  cell's  environment  and  is  well  known  to  influence 
differentiation  and  development  in  many  cell  types  (Hay, 
1981).  Collagen is a basic part of the matrix and our results 
support earlier work suggesting its importance to myogenic 
differentiation.  In addition, a critical role for the myoblasts 
in modifying or creating  the matrix is indicated  by the re- 
quirement for the actual  synthesis of procollagen.  Further 
work will be necessary to define its role. 
This work was supported by grants from the Medical Research Council of 
Canada. 
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